Fibroscan
Payments companies reported to CMS as associated with Fibroscan. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Fibroscan, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Fibroscan
These are the largest totals companies reported as associated with Fibroscan. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stephen Harrison | Live Oak, TX | Gastroenterology (Internal Medicine) | $80,219.46 |
| Martin Grajower | Bronx, NY | Endocrinology, Diabetes & Metabolism | $63,422.10 |
| Tejas Joshi | Huntington, WV | Hepatology | $50,814.63 |
| Joel Brill | Paradise Valley, AZ | Gastroenterology (Internal Medicine) | $36,713.69 |
| Bradley Anderson | Columbia, MO | Gastroenterology (Internal Medicine) | $19,816.05 |
| Naim Alkhouri | Westlake, OH | Gastroenterology (Internal Medicine) | $18,617.54 |
| Darryn Potosky | Laurel, MD | Gastroenterology (Internal Medicine) | $15,623.58 |
| Mazen Noureddin | Houston, TX | Gastroenterology (Internal Medicine) | $7,868.26 |
| Raj Vuppalanchi | Indianapolis, IN | Internal Medicine | $7,820.61 |
| Sreedevi Reddy | Scottsdale, AZ | Endocrinology, Diabetes & Metabolism | $6,300.00 |
Prescribed Fibroscan?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.